Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant

American Journal of Ophthalmology

Volumn 127, Issue 3, 1999, Pages 276-282

  Roth, Daniel B ^a   Feuer, William J ^a   Blenke, Anita J ^a   Davis, Janet L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; INTRAVITREAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINITIS; VISUAL ACUITY;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS RETINITIS; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; GANCICLOVIR; HUMANS; MALE; RECURRENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0033104549     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(98)00440-1     Document Type: Article

References (28)

1. Jabs D.A., Enger C., Bartlett J.G. CMV retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 107:1989;75-80.
2. Palestine A.G., Rodrigues M.M., Macher A.M., et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 91:1984;1092-1099.
3. Kupperman B.D., Petty J.G., Richman D.D., et al. Correlation between CD4+ counts and prevalence of CMV retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 115:1993;575-582.
4. Gallant J.E., More R.D., Richman D.D., et al. Incidence and natural history of CMV disease in patients with advanced human immunodeficiency virus disease treated with zidovudine the Zidovudine Study Group. J Infect Dis. 166:1992;1223-1227.
5. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trial Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for CMV retinitis. N Engl J Med. 326:1992;213-220.
6. Holland G.N., Sidikaro Y., Krieger A.E., et al. Treatment of CMV retinopathy with ganciclovir. Ophthalmology. 94:1987;815-823.
7. Jabs D.A., Newman C., De Bustros S., Polk B.F. Treatment of CMV retinitis with ganciclovir. Ophthalmology. 94:1987;824-830.
8. LeHoang P., Girard B., Robinet M., et al. Foscarnet in the treatment of CMV retinitis in acquired immune deficiency syndrome. Ophthalmology. 96:1989;865-873.
9. Palestine A.G., Polis M.A., De Smet M.D., et al. A randomized, controlled trial of foscarnet in the treatment of CMV retinitis in patients with AIDS. Ann Intern Med. 115:1991;665-673.
10. Sanborn G.E., Anand R., Torti R.E., et al. Sustained-release ganciclovir therapy for treatment of CMV retinitis use of an intravitreal device. Arch Ophthalmol. 110:1992;188-195.
11. Smith T.J., Pearson P.A., Blandford D.L., et al. Intravitreal sustained-release ganciclovir. Arch Ophthalmol. 110:1992;255-258.
12. Anand R., Font R.L., Fish R.H., Nightingale S.D. Pathology of CMV retinitis treated with sustained release intravitreal ganciclovir. Ophthalmology. 100:1993;1032-1039.
13. Anand R., Nightingale S.D., Fish R.H., Smith T.J., Ashton P. Control of CMV retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 111:1993;223-227.
14. Martin D.F., Parks D.J., Mellow S.D., et al. Treatment of CMV retinitis with an intraocular sustained-release ganciclovir implant a randomized controlled clinical trial. Arch Ophthalmol. 112:1994;1531-1539.
15. Musch D.C., Martin D.F., Gordon J.F., et al. Treatment of CMV retinitis with a sustained-release ganciclovir implant. N Engl J Med. 337:1997;83-90.
16. Marx J.L., Kapusta M.A., Patel S.S., et al. Use of the ganciclovir implant in the treatment of recurrent CMV retinitis. Arch Ophthalmol. 114:1996;815-820.
17. Hatton M.P., Duker J.S., Reichel E., Morley M.G., Puliafito C.A. Treatment of relapsed CMV retinitis with the sustained-release ganciclovir implant. Retina. 18:1998;50-55.
18. Kuppermann B.D., Quiceno J.I., Flores-Aguilar M., et al. Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with CMV retinitis implications for therapy. J Infect Dis. 168:1993;1506-1509.
19. Davis J., Gautier S., O'Grady O., Parel J.M. Intravitreal ganciclovir concentration after oral intravenous and intravitreal administration in AIDS patients with CMV retinitis. Invest Ophthalmol Vis Sci. 389:(suppl):1997;S1100.
20. Drew W.L., Miner R.C., Busch D.F., et al. Prevalence of resistance in patients receiving ganciclovir for serious CMV infection. J Infect Dis. 163:1991;716-719.
21. Drew W.L., Miner R.C., Saleh E. Antiviral susceptibility of CMV criteria for detecting resistance to antivirals. Clin Diagn Virol. 1:1993;179-185.
22. Jacobson M.A., Drew W.L., Feinberg J., et al. Foscarnet therapy for ganciclovir-resistant CMV retinitis in patients with AIDS. J Infect Dis. 163:1991;1348-1351.
23. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trial Group. CMV culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. J Infect Dis. 176:1997;50-58.
24. Erice A., Chou S., Biron K.K., et al. Progressive disease due to ganciclovir-resistant CMV in immunocompromised patients. N Engl J Med. 320:1989;289-293.
25. Dunn J.P., MacCumber M.W., Forman M.S., et al. Viral sensitivity testing in patients with CMV retinitis clinically resistant to foscarnet or ganciclovir. Am J Ophthalmol. 119:1995;587-596.
26. Studies of the Ocular Complications of AIDS Research Group, AIDS Clinical Trial Group. Foscarnet-ganciclovir CMV retinitis trial, 4 visual outcomes. Ophthalmology. 101:1994;1250-1261.
27. Freeman W.R., Henderly D.E., Wan W.L., et al. Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated CMV retinitis. Am J Ophthalmol. 103:1986;527-536.
28. Jabs D.A., Enger C., Haller J., de Bustros S. Retinal detachments in patients with CMV retinitis. Arch Ophthalmol. 109:1991;794-799.